Jonathan C. Javitt, Director at BRAINSTORM CELL THERAPEUTICS INC (BCLI), sold 40,000 shares at $0.25 ($10K) on 2008-08-27, disclosed to the SEC on 2008-08-28.
Open-market sale of $10k BCLI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NRXP | BUY | 2023-08-23 | $64K | — | Filing → |
| NRXP | SELL | 2022-12-09 | $400K | — | Filing → |
| NRXP | BUY | 2022-06-02 | $5.8M | — | Filing → |